Combangio
California
About Combangio
Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics based on mesenchymal stem cell secretomes.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $15.0M
- Funding stage: M&A
- Last round: Grant (Apr 2023)
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/combangio-30300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.